Connect Biopharma Holdings Limited (CNTB) vs Envoy Medical, Inc. (COCH)

A side-by-side comparison of Connect Biopharma Holdings Limited and Envoy Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CNTB vs COCH

growth of $100 · dividends reinvested · last 5y
CNTB -94.2% (-43.5%/yr)COCH -93.3% (-41.8%/yr)COCH compounded faster over this window
050100150Start $10020222023202420252026$6$7
CNTB COCH

CNTB vs COCH: by the numbers

  • •CNTB is the larger company ($57M vs $50M market cap).
  • •Both run net losses; COCH's is the smaller (-11304.83% vs -86687.50% net margin).

Metrics side by side

Valuation

MetricCNTBCOCH
P/S ratioN/A242.77
P/B ratio2.1015.21

Profitability

MetricCNTBCOCH
Gross margin100.00%-262.66%
Operating margin-90740.62%-9240.66%
Net margin-86687.50%-11304.83%
ROE-132.16%-708.48%
ROIC-136.77%-208.76%

Growth (annualized)

MetricCNTBCOCH
Total return CAGR (5Y)-47.22%-41.73%

Frequently asked

How have CNTB and COCH total returns compared?
Over the past 5 years, CNTB delivered -47.22% and COCH delivered -41.73% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.